NCT00968851 Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT00805376 DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas Status COMPLETED Phase PHASE1
NCT00780078 Clinical Evaluation of Swallowing Disorders as a Predictor of Extubation Failure Status COMPLETED Phase N/A
NCT00766363 Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00709852 Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging Status COMPLETED Phase PHASE3
NCT00649207 A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases Status COMPLETED Phase PHASE1
NCT00623467 Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging Status COMPLETED Phase PHASE3
NCT00537017 Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) Status COMPLETED Phase PHASE2
NCT00395460 Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients Status COMPLETED Phase PHASE3
NCT00110331 Central Nervous System Disease in HIV-infected Children on HAART Status COMPLETED Phase N/A